Menu
Back to Dove Press podcast topics » International Journal of Chronic Obstructive Pulmonary Disease » International Journal of COPD podcast series » ATS guidelines in COPD: When is one therapy not enough?
ATS guidelines in COPD: When is one therapy not enough?
Dr Richard Russell and Professor Michael Dreher present the 2020 American Thoracic Society Guidelines on the management of COPD,1 to which Professor Dreher was a key contributor. Listen as the experts deliberate on the use of dual bronchodilation and inhaled corticosteroids in patients with COPD, as well as reviewing conditional and strong recommendations for treatment, according to the guidelines.1,2 Dr Russell will also discuss the findings of a publication about maintenance inhaler therapy preferences of patients with COPD.3 Finally, Dr Russell will delve into the social media hot topic of air pollution and the effects it can have on patients with COPD.
1 Nici L, et al. Am J Respir Crit Care Med 2020;201:e56–e69;
2 Global Initiative for Chronic Obstructive Lung Disease. Updated 2022. Available here. Last accessed: November 2021;
3 Tervonen T, et al. Thorax 2020;75:735–743
Disclosures
Professor Michael Dreher
Professor Michael Dreher reports speaker fees from Actelion Pharmaceuticals, AstraZeneca, Bayer, Berlin-Chemie, Boehringer Ingelheim, Chiesi, Hamilton, Heinen und Löwenstein, Linde, Novartis, Pfizer, Philips Respironics, ResMed, Roche and Weinmann. He also reports consulting fees from Almirall, Boehringer Ingelheim, Linde, Novartis, Pfizer, Philips Respironics, ResMed and Roche, and research grants from Linde, Philips Respironics and ResMed.
Bios:
 |
Professor Michael Dreher Professor Michael Dreher is the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany). He is Member of the Board of Trustees of the "Deutsche Lungenstiftung“and management board member of several German societies, including the German Airway League. Prof Dreher's research interests focus on the management of chronic obstructive pulmonary disease and other lung diseases, and also include aspects of critical care medicine. |
This series of podcasts are intended for healthcare professionals only.
The Medical Insider COPD podcast series discusses hot topics in the world of COPD with those who know it best, aiming to spread information, debunk myths and improve the lives of patients. The Editorial Board of the Medical Insider COPD podcast is comprised of Professor James Chalmers, the British Lung Foundation Chair of Respiratory Research at the University of Dundee (UK), Professor Michael Dreher, the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany), and the host and moderator, Dr Richard Russell, a Consultant Chest Physician at Lymington New Forest Hospital (UK), a Senior Clinical Researcher at the University of Oxford (UK) and the founding editor of the International Journal of COPD. These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.
Copyright © 2021, Boehringer Ingelheim Group of Companies. All rights reserved.
Publish time: 15 December 2021
Episode number: 3
Duration: 22 minutes 2 seconds